<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Benign Prostatic Enlargement (BPE) - Okell Surgery Notes</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="05-anorectal-malformations.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 10%;"></div>
                        </div>
                       <span class="progress-text">Topic 6 of 60</span>
                    </div>
                    <a href="07-bladder-carcinoma.html" class="nav-button">
                        <span class="nav-text">Next: Bladder Carcinoma</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">BENIGN PROSTATIC ENLARGEMENT (BPE)</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: etiology-pathophysiology -->
                <section id="etiology-pathophysiology" class="content-section">
                    <h2 class="section-heading">Etiology & Pathophysiology</h2>
                    <div class="content-card">
                        <h3>Etiology</h3>
                        <p>Thought to related to:</p>
                        <ol class="enhanced-list">
                            <li><strong>Hormones:</strong> balance between testosterone, estrogen, prolactin and growth factors.</li>
                            <li><strong>Age:</strong> the mesenchymal theory that apoptosis of cells is slowed in favor of cell proliferation with advancing age.</li>
                        </ol>

                        <h3>Pathophysiology</h3>
                        <p>Symptoms of benign prostatic hyperplasia related to either the obstructive component of the prostate or to the secondary response of the bladder to the outlet resistance. Obstruction can be due to either mechanical or dynamic.</p>
                        <p><strong>Mechanical obstruction:</strong> As prostatic enlargement occurs, intrusion into the urethral lumen or bladder neck results in higher bladder outlet resistance. Prostatic size on digital rectal examination (DRE) correlates poorly with symptoms.</p>
                        <p><strong>Dynamic component:</strong> Explains the variable nature of the symptoms. The prostatic stroma is composed of smooth muscle and collagen and is rich in adrenergic nerve supply. Level of autonomic stimulation thus sets a "tone" to the prostatic urethra. Alpha-blocker therapy decreases this tone, resulting in a decrease in outlet resistance.</p>
                        <p><strong>Irritative symptoms:</strong> Result from the secondary response of the bladder to the increased outlet resistance. Bladder outlet obstruction results in detrusor muscle hypertrophy and hyperplasia as well as collagen deposition. This leads to a decrease in bladder compliance and detrusor instability. Also due to chemical deposits from urine on the bladder wall stimulating contractility.</p>
                    </div>
                </section>
                <!-- END: etiology-pathophysiology -->

                <!-- START: clinical-presentation -->
                <section id="clinical-presentation" class="content-section">
                    <h2 class="section-heading">Clinical Presentation</h2>
                    <div class="content-card">
                        <h3>History</h3>
                        <p>Age usually greater than 40 years. With both irritative and obstructive urinary symptoms.</p>

                        <h4>Irritative Symptoms</h4>
                        <ul class="enhanced-list">
                            <li>Nocturia</li>
                            <li>Frequency</li>
                            <li>Urgency/urge incontinence</li>
                            <li>Dysuria</li>
                        </ul>

                        <h4>Obstructive symptoms</h4>
                        <ul class="enhanced-list">
                            <li>Intermittency/hesitancy</li>
                            <li>Poor urinary stream</li>
                            <li>Incomplete emptying and dribbling</li>
                            <li>Straining</li>
                        </ul>

                        <h4>Complications</h4>
                        <ul class="enhanced-list">
                            <li><strong>Acute urinary retention:</strong> Suprapubic pain, Complete inability to pass urine</li>
                            <li><strong>Chronic urinary retention:</strong> Usually painless, Can pass some urine</li>
                            <li><strong>UTI:</strong> Fever, Dysuria and frequency</li>
                            <li><strong>Pyelonephritis:</strong> flank pains, fever and vomiting</li>
                            <li><strong>Renal failure:</strong> Leg edema, scrotal edema</li>
                        </ul>

                        <h3>Physical examination</h3>
                        <p><strong>General:</strong> Anemia (chronic renal failure), Pitting edema, Fever (UTI).</p>
                        <p><strong>Abdominal examination:</strong> Suprapubic distension (acute retention), Flank distension (Hydronephrosis), Suprapubic tenderness.</p>
                        <p><strong>DRE (Digital Rectal Exam):</strong></p>
                        <ul class="enhanced-list">
                            <li>Normal anal sphincter tone.</li>
                            <li>Prostate is firm, smooth and mucosa over is mobile.</li>
                            <li>Medial sulcus felt, the symmetry maintained.</li>
                        </ul>
                        <p><strong>Neurological examination:</strong> Tests for the sacral plexus to rule out any cause of neurogenic bladder (Perianal sensation, anal wink, S1-S3 dermatomes).</p>
                    </div>
                </section>
                <!-- END: clinical-presentation -->

                <!-- START: investigations -->
                <section id="investigations" class="content-section">
                    <h2 class="section-heading">Investigations</h2>
                    <div class="content-card">
                        <h3>Laboratory</h3>
                        <ol class="enhanced-list">
                            <li><strong>FHG:</strong> WBC (rule out UTI), ESR, CRP.</li>
                            <li><strong>Urinalysis:</strong> Nitrites (UTI), Hematuria, Microscopy.</li>
                            <li><strong>U/E/C:</strong> Rule out obstructive uropathy (Renal failure).</li>
                            <li><strong>PSA (Prostate Specific Antigen):</strong>
                                <p>Usually age dependent but 0-4 ng/dl regarded as normal range.</p>
                                <div class="table-container">
                                    <table>
                                        <tr><td>0-49 years</td><td>2.5 ng/dl</td></tr>
                                        <tr><td>50-59 years</td><td>3.5 ng/dl</td></tr>
                                        <tr><td>60-69 years</td><td>4.5 ng/dl</td></tr>
                                        <tr><td>70-79 years</td><td>5.5 ng/L</td></tr>
                                        <tr><td>>90 years</td><td>>6.5 ng/dl</td></tr>
                                    </table>
                                </div>
                                <p><strong>Other conditions increasing PSA:</strong> Prostatitis, Prostatic infarction, DRE/massage, Sexual intercourse, Instrumentation, Cancer.</p>
                                <p><strong>Predictive value for cancer:</strong> 0-4 ng/dl (5%), 4-10 ng/dl (25%), >10 ng/dl (>65%).</p>
                            </li>
                            <li><strong>Diabetic Neuropathy:</strong> RBS.</li>
                            <li><strong>Urine flow rate:</strong> Qmax cut off for intervention is 10 ml/sec. (Normal male: 20-25 ml/sec).</li>
                        </ol>

                        <h3>Imaging</h3>
                        <ol class="enhanced-list">
                            <li><strong>Abdominal ultrasound:</strong> Evaluate Post void residual urine (Normal <30mL), Prostate size, Upper urinary tract (Hydronephrosis).</li>
                            <li><strong>Transrectal U/S (TRUS) ± TruCut Biopsy</strong></li>
                            <li><strong>IVU:</strong> Indicated if features of RF.</li>
                            <li><strong>Urodynamic studies (MCU):</strong> Rule out strictures, calculi.</li>
                            <li><strong>Pressure-flow studies:</strong> For neurological disorders. Maximum intravesical pressure < 60 mmHg implies poor contractility.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: investigations -->

                <!-- START: management -->
                <section id="management" class="content-section">
                    <h2 class="section-heading">MANAGEMENT</h2>
                    <div class="content-card">
                        <h3>A. Acute Urine Retention</h3>
                        <p>Relieve the obstruction by catheterization (Suprapubic or transurethral). Usually use foley's catheter (gauge 16 or 18).</p>
                        
                        <h4>Catheterization procedure</h4>
                        <ol class="enhanced-list">
                            <li>Aseptic technique, Clean and drape genitalia.</li>
                            <li>Lubricate foleys catheter with K-Y jelly.</li>
                            <li>Insert catheter, advance to hilt (ensure balloon is not in urethra).</li>
                            <li>Inflate balloon (usually 5-10 mL sterile water).</li>
                            <li>Connect to drainage bag.</li>
                        </ol>
                        <p><strong>Post-Catheterization Care:</strong> Keep on catheter for 2 weeks. Start prophylactic antibiotics. Offer medical therapy.</p>

                        <h4>Medical Therapy</h4>
                        <ul class="enhanced-list">
                            <li><strong>Alpha-blockers:</strong> (For Prostate < 40 cm³) Prazosine, Terazosin, Doxazosine, Tamulsine, Alfuzosine. Decrease smooth muscle tone. S/E: Dizziness, hypotension, retrograde ejaculation.</li>
                            <li><strong>5α-reductase inhibitors:</strong> (For Prostate > 40 cm³) Finasteride, Dutasteride. Reduce testosterone conversion to DHT. S/E: Loss of libido, impotence.</li>
                            <li><strong>Phytotherapy:</strong> Saw palmetto, Pygium africanum.</li>
                        </ul>

                        <aside class="callout note">
                            <h4 class="callout-title">Trial Without Catheter (TWOC)</h4>
                            <p>After two weeks, do a trial without catheter. If flow rate > 10 mls/sec, manage based on IPSS score (Watchful waiting for mild/moderate). If flow rate < 10 mls/sec and severe IPSS, surgical review.</p>
                        </aside>

                        <h3>B. Indications for Surgery</h3>
                        <ol class="enhanced-list">
                            <li>Recurrent urinary retention</li>
                            <li>Flow rate less than 10 ml/second</li>
                            <li>Deteriorating IPSS score</li>
                            <li>Failed medical therapy</li>
                            <li>Upper urinary tract complications (hydronephrosis)</li>
                            <li>Recurrent/refractory UTI</li>
                            <li>Renal failure</li>
                            <li>Prostatic calculi</li>
                            <li>Haemorrhage</li>
                            <li>Patient preference/Quality of life</li>
                        </ol>

                        <h3>Surgical Options</h3>
                        <h4>Transurethral Procedures</h4>
                        <ul class="enhanced-list">
                            <li><strong>TURP (Transurethral Resection of the Prostate):</strong> Standard for glands 50-70g. Low morbidity.</li>
                            <li><strong>TUIP (Transurethral Incision):</strong> For small glands (<30g). Relieves pressure with minimal destruction.</li>
                        </ul>

                        <h4>Open Procedures</h4>
                        <p>For larger prostates (>75g).</p>
                        <ul class="enhanced-list">
                            <li><strong>Transvesical prostatectomy (Frayer's)</strong></li>
                            <li><strong>Retropubic prostatectomy (Milin's)</strong></li>
                        </ul>

                        <h4>Complications of TURP</h4>
                        <ul class="enhanced-list">
                            <li>Haemorrhage</li>
                            <li>Infection</li>
                            <li>Retrograde ejaculation (65%)</li>
                            <li>Erectile Dysfunction (≤14%)</li>
                            <li>Urethral stricture</li>
                            <li><strong>TURP Syndrome:</strong> Dilutional hyponatremia due to absorption of irrigation fluid (Glycine). Symptoms: Hypertension then hypotension, bradycardia, confusion, seizures. Mx: Diuresis (Furosemide + Mannitol).</li>
                        </ul>
                    </div>
                </section>
                <!-- END: management -->

                <!-- START: ipss-score -->
                <section id="ipss-score" class="content-section">
                    <h2 class="section-heading">International Prostate Symptom Score (IPSS)</h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table>
                                <thead>
                                    <tr>
                                        <th>Symptom</th>
                                        <th>Not at all (0)</th>
                                        <th>< 1 in 5 (1)</th>
                                        <th>< Half (2)</th>
                                        <th>~ Half (3)</th>
                                        <th>> Half (4)</th>
                                        <th>Almost Always (5)</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Incomplete emptying</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Frequency</strong> (< 2 hrs)</td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Intermittency</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Urgency</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Weak stream</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Straining</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Nocturia</strong></td>
                                        <td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><strong>Scoring:</strong></p>
                        <ul class="enhanced-list">
                            <li><strong>0-7:</strong> Mildly symptomatic</li>
                            <li><strong>8-19:</strong> Moderately symptomatic</li>
                            <li><strong>20-35:</strong> Severely symptomatic</li>
                        </ul>
                        <p><strong>Quality of Life Question:</strong> "If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?" (Score 0 Delighted to 6 Terrible)</p>
                    </div>
                </section>
                <!-- END: ipss-score -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="05-anorectal-malformations.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 10%;"></div>
                        </div>
                       <span class="progress-text">Topic 6 of 60</span>
                    </div>
                    <a href="07-bladder-carcinoma.html" class="nav-button">
                        <span class="nav-text">Next: Bladder Carcinoma</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>